English
Korean
GBIOLOGICS

Biotechnology company

GBIOLOGICS
홈으로
GBIOLOGICS
History
History
2022

GLP-TOX studies ongoing

SLE, RA, Cancer efficacy studies ongoing

2021

GB920 Joint Research
and Development
Agreement singed with PLATBIO

Series A Fundrasing closed: USD 10M

GB910/RA new use patent registered

2020

sGal-9 Manufacturing process established

2019

Venture Company Certification(제20190402684호)

GBIO Lab Foundation

2018

sGal-9 new material patent(USA/Japan)
ownership acquired

Incorporation of GBIOLOGICS